• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍诱导H4IIE肝癌细胞的脂肪生成和凋亡。

Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.

作者信息

Park Deokbae, Lee Sookyoung, Boo Hyejin

机构信息

Department of Histology, Jeju National University College of Medicine, Jeju 63243, Korea.

出版信息

Dev Reprod. 2023 Jun;27(2):77-89. doi: 10.12717/DR.2023.27.2.77. Epub 2023 Jun 30.

DOI:10.12717/DR.2023.27.2.77
PMID:37529015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390098/
Abstract

Metformin is the most widely used anti-diabetic drug that helps maintain normal blood glucose levels primarily by suppressing hepatic gluconeogenesis in type II diabetic patients. We previously found that metformin induces apoptotic death in H4IIE rat hepatocellular carcinoma cells. Despite its anti-diabetic roles, the effect of metformin on hepatic de novo lipogenesis (DNL) remains unclear. We investigated the effect of metformin on hepatic DNL and apoptotic cell death in H4IIE cells. Metformin treatment stimulated glucose consumption, lactate production, intracellular fat accumulation, and the expressions of lipogenic proteins. It also stimulated apoptosis but reduced autophagic responses. These metformin-induced changes were clearly reversed by compound C, an inhibitor of AMP-activated protein kinase (AMPK). Interestingly, metformin massively increased the production of reactive oxygen species (ROS), which was completely blocked by compound C. Metformin also stimulated the phosphorylation of p38 mitogen-activated protein kinase (p38MAPK). Finally, inhibition of p38MAPK mimicked the effects of compound C, and suppressed the metformin-induced fat accumulation and apoptosis. Taken together, metformin stimulates dysregulated glucose metabolism, intracellular fat accumulation, and apoptosis. Our findings suggest that metformin induces excessive glucose-induced DNL, oxidative stress by ROS generation, activation of AMPK and p38MAPK, suppression of autophagy, and ultimately apoptosis.

摘要

二甲双胍是应用最广泛的抗糖尿病药物,主要通过抑制II型糖尿病患者的肝糖异生来帮助维持正常血糖水平。我们之前发现二甲双胍可诱导H4IIE大鼠肝癌细胞发生凋亡性死亡。尽管二甲双胍具有抗糖尿病作用,但其对肝脏从头脂肪生成(DNL)的影响仍不清楚。我们研究了二甲双胍对H4IIE细胞肝脏DNL和凋亡性细胞死亡的影响。二甲双胍处理可刺激葡萄糖消耗、乳酸生成、细胞内脂肪积累以及脂肪生成蛋白的表达。它还刺激细胞凋亡,但减少自噬反应。这些二甲双胍诱导的变化被AMP激活的蛋白激酶(AMPK)抑制剂化合物C明显逆转。有趣的是,二甲双胍大量增加活性氧(ROS)的产生,而这被化合物C完全阻断。二甲双胍还刺激p38丝裂原活化蛋白激酶(p38MAPK)的磷酸化。最后,抑制p38MAPK模拟了化合物C的作用,并抑制了二甲双胍诱导的脂肪积累和细胞凋亡。综上所述,二甲双胍刺激失调的葡萄糖代谢、细胞内脂肪积累和细胞凋亡。我们的研究结果表明,二甲双胍诱导过度的葡萄糖诱导的DNL、通过ROS生成引起的氧化应激、AMPK和p38MAPK的激活、自噬的抑制,并最终导致细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/9e0ff2368f09/dr-27-2-77-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/aa20277f0b72/dr-27-2-77-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/f0194589372d/dr-27-2-77-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/77f7a95299c2/dr-27-2-77-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/9e0ff2368f09/dr-27-2-77-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/aa20277f0b72/dr-27-2-77-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/f0194589372d/dr-27-2-77-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/77f7a95299c2/dr-27-2-77-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/10390098/9e0ff2368f09/dr-27-2-77-g4.jpg

相似文献

1
Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.二甲双胍诱导H4IIE肝癌细胞的脂肪生成和凋亡。
Dev Reprod. 2023 Jun;27(2):77-89. doi: 10.12717/DR.2023.27.2.77. Epub 2023 Jun 30.
2
Metformin Promotes Apoptosis but Suppresses Autophagy in Glucose-Deprived H4IIE Hepatocellular Carcinoma Cells.二甲双胍促进葡萄糖剥夺的H4IIE肝癌细胞凋亡但抑制自噬。
Diabetes Metab J. 2015 Dec;39(6):518-27. doi: 10.4093/dmj.2015.39.6.518.
3
Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells.二甲双胍在 H4IIE 肝癌细胞中诱导氧化应激介导的细胞凋亡,而不阻断糖酵解。
Biol Pharm Bull. 2019;42(12):2002-2008. doi: 10.1248/bpb.b19-00474.
4
Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest.芬苯达唑通过 p21 介导的细胞周期阻滞抑制活跃生长的 H4IIE 肝癌细胞的生长并诱导其凋亡。
Biol Pharm Bull. 2022;45(2):184-193. doi: 10.1248/bpb.b21-00697.
5
Metformin attenuates cadmium-induced neuronal apoptosis in vitro via blocking ROS-dependent PP5/AMPK-JNK signaling pathway.二甲双胍通过阻断 ROS 依赖的 PP5/AMPK-JNK 信号通路减轻体外镉诱导的神经元凋亡。
Neuropharmacology. 2020 Sep 15;175:108065. doi: 10.1016/j.neuropharm.2020.108065. Epub 2020 Mar 21.
6
Metformin alleviates high glucose-mediated oxidative stress in rat glomerular mesangial cells by modulation of p38 mitogen-activated protein kinase expression in vitro.二甲双胍通过体外调节p38丝裂原活化蛋白激酶的表达减轻高糖介导的大鼠肾小球系膜细胞氧化应激。
Mol Med Rep. 2015 Jul;12(1):520-6. doi: 10.3892/mmr.2015.3446. Epub 2015 Mar 6.
7
Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.2-脱氧-D-葡萄糖与二甲双胍联合用于协同抑制非小细胞肺癌:一种活性氧和P-p38介导的机制。
Biomed Pharmacother. 2016 Dec;84:1575-1584. doi: 10.1016/j.biopha.2016.10.037. Epub 2016 Nov 5.
8
Metformin prevents an adaptive increase in GSH and induces apoptosis under the conditions of GSH deficiency in H4IIE cells.二甲双胍可防止H4IIE细胞中谷胱甘肽(GSH)适应性增加,并在GSH缺乏的条件下诱导细胞凋亡。
J Toxicol Environ Health A. 2007 Aug;70(15-16):1371-80. doi: 10.1080/15287390701434430.
9
Cardiac glycoside sensitized hepatocellular carcinoma cells to TRAIL via ROS generation, p38MAPK, mitochondrial transition, and autophagy mediation.强心苷通过 ROS 生成、p38MAPK、线粒体转换和自噬介导使肝癌细胞对 TRAIL 敏感。
Mol Carcinog. 2019 Nov;58(11):2040-2051. doi: 10.1002/mc.23096. Epub 2019 Aug 8.
10
Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro.芪苈强心,一种复方草药配方,通过抑制 ROS/AMPK/mTOR 通路,减轻体外缺氧复氧诱导的细胞凋亡和自噬死亡。
J Integr Med. 2022 Jul;20(4):365-375. doi: 10.1016/j.joim.2022.04.005. Epub 2022 Apr 27.

引用本文的文献

1
Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells.脂肪酸合酶(FASN)抑制剂可抑制二甲双胍诱导的H4IIE肝癌细胞脂肪堆积和凋亡。
Dev Reprod. 2024 Dec;28(4):163-174. doi: 10.12717/DR.2024.28.4.163. Epub 2024 Dec 31.
2
Anti-Diabetic Therapies and Cancer: From Bench to Bedside.抗糖尿病治疗与癌症:从基础到临床。
Biomolecules. 2024 Nov 20;14(11):1479. doi: 10.3390/biom14111479.
3
Metformin Inefficiency to Lower Lipids in Vitamin B12 Deficient HepG2 Cells Is Alleviated via Adiponectin-AMPK Axis.

本文引用的文献

1
AMPK activation by AICAR reduces diet induced fatty liver in C57BL/6 mice.AICAR 通过激活 AMPK 减少 C57BL/6 小鼠的饮食诱导性脂肪肝。
Tissue Cell. 2023 Jun;82:102054. doi: 10.1016/j.tice.2023.102054. Epub 2023 Mar 2.
2
Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC.USP1 的抑制通过泛素蛋白聚集激活 ER 应激,从而诱导 HCC 中的自噬和细胞凋亡。
Cell Death Dis. 2022 Nov 10;13(11):951. doi: 10.1038/s41419-022-05341-3.
3
Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways.
维生素 B12 缺乏的 HepG2 细胞中二甲双胍降低脂质的效率通过脂联素-AMPK 轴得到改善。
Nutrients. 2023 Dec 8;15(24):5046. doi: 10.3390/nu15245046.
次野鸢尾黄素通过 TLR4/p38 MAPK 和 SIRT1 相关通路改善脂毒性诱导的肝细胞损伤和脂肪变性。
Oxid Med Cell Longev. 2022 Mar 20;2022:4557532. doi: 10.1155/2022/4557532. eCollection 2022.
4
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer.LXRα 激活和 Raf 抑制引发肝癌中的致命脂毒性。
Nat Cancer. 2021 Feb;2(2):201-217. doi: 10.1038/s43018-020-00168-3. Epub 2021 Feb 15.
5
Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication.肝脏P38激活通过Fgf21介导的器官间通讯调节全身代谢。
Diabetes. 2021 Oct 21. doi: 10.2337/db21-0240.
6
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.RIT1 过表达激活 RAS/MAPK 信号通路,并增强肝癌对索拉非尼和 AKT 抑制剂联合治疗的敏感性。
Oncogene. 2022 Jan;41(5):732-744. doi: 10.1038/s41388-021-02130-8. Epub 2021 Nov 29.
7
Mechanism of interaction between autophagy and apoptosis in cancer.癌症中自噬与凋亡之间的相互作用机制。
Apoptosis. 2021 Oct;26(9-10):512-533. doi: 10.1007/s10495-021-01687-9. Epub 2021 Sep 12.
8
Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.二甲双胍对肝脏的作用:肝细胞和免疫细胞中与 NASH 相关 HCC 的保护机制。
Int J Mol Sci. 2021 May 9;22(9):5016. doi: 10.3390/ijms22095016.
9
Antitumor Activity of Combination Therapy with Metformin and Trametinib in Non-Small Cell Lung Cancer Cells.二甲双胍与曲美替尼联合治疗对非小细胞肺癌细胞的抗肿瘤活性
Dev Reprod. 2020 Jun;24(2):113-123. doi: 10.12717/DR.2020.24.2.113. Epub 2020 Jun 30.
10
NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway.NOD2 通过靶向 AMPK 通路抑制肝癌的发生发展并增加其化疗敏感性。
Cell Death Dis. 2020 Mar 6;11(3):174. doi: 10.1038/s41419-020-2368-5.